Has Anthony Alexander, MD received payments from drug or device companies?

Yes. Drug and device makers reported $847 in general payments to Anthony Alexander, MD across 16 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anthony Alexander, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anthony Alexander, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anthony Alexander, MD

Interventional Pain Medicine · Seymour, INNPI 1508949827

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Stimwave Technologies Incorporated at 28.0% of the total. Reporting peaked in 2019 at $472 and has fallen 79.5% since, to $97 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IN, where the typical reported total is $4,157.

$847in general payments, 2019–2025

Across 16 payments — averaging $52.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stimwave Technologies Incorporated$237
Vertos Medical, Inc.$207
GRT US Holding, Inc.$183
Lilly USA, LLC$84
Boston Scientific$43
Medtronic$29
plus $63 from 3 others

$5,734in research payments, 2019–2025

Across 11 payments — averaging $521.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertos Medical, Inc.$6K

What the payments were for

Food & beverage$847100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stimwave Technologies Incorporated	4	$237
Vertos Medical, Inc.	2	$207
GRT US Holding, Inc.	1	$183
Lilly USA, LLC	2	$84
Boston Scientific	2	$43
Medtronic(2 entities)	2	$29
Abbott	1	$26
Biotronik NRO, Inc.	1	$18
Globus Medical	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Qutenza$183
mild Device Kit$159

How this compares

$847 in reported general payments places this provider in the 20th percentile of 68 interventional pain medicine providers in Indiana.

See all interventional pain medicine providers in Indiana →

Medicare billing

Part B allowed, 2024

$200,706

Medicare patients

123

Services billed

2,195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	877	$33,066
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	749	$23,753
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	419	$22,774
Fentanyl	80	$11,315
SavellaMilnacipran Hcl	26	$10,680
Morphine Sulfate ErMorphine Sulfate	139	$5,900
MovantikNaloxegol Oxalate	11	$4,548
Methadone Hcl	180	$4,287
Nucynta ErTapentadol Hcl	11	$3,594
Zonisamide	71	$2,623
Gabapentin	171	$1,685
Tizanidine Hcl	232	$1,541
Pregabalin	48	$1,196
Morphine Sulfate	29	$1,137
Baclofen	65	$828

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Seymour

Nwadi IgweSeymour$5K
Joshua WellingtonCarmel$315K
Joseph RutledgeLafayette$96K
Orlando LandrumElkhart$34K
Mahendra SanapatiEvansville$31K
Nikhil ShettyMunster$29K
David GordonIndianapolis$28K
Vinayak BelamkarIndianapolis$28K
Jocelyn BushIndianapolis$20K
Scott KimGreenwood$18K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →